Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.9 INR | -0.12% | +6.30% | +10.85% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.85% | 2.44B | |
+48.29% | 780B | |
+41.76% | 627B | |
+19.63% | 334B | |
+6.69% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.45% | 161B | |
-4.12% | 159B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy